Bookmark list

Subscribe to newsletter

YM BioSciences' partner, Oncoscience AG, cleared for Phase III trial in Germany with nimotuzumaby

30-Mar-2006

High-quality recirculating chillers with natural refrigerant

Real-time PCR thermal cycler qTOWER iris

High-throughput screening of 1536 samples in just 27 seconds: The fastest microplate reader on the market

YM BioSciences Inc. announced that its partner, Oncoscience AG, has been cleared by the German regulatory authority for biological products, the Paul Ehrlich Institute, to initiate a Phase III trial of nimotuzumab in combination with radiation in children with inoperable pontine (brain stem) glioma. The clinical trial was also reviewed with the EMEA and is designed as a prospectively registrable study on the basis of a single arm trial because of the absence of treatment options for children suffering from pontine glioma. It is anticipated that marketing authorization subsequent to a successful trial would be sought under the EMEA centralized procedure.

https://www.bionity.com/en/news/53577/ym-biosciences-partner-oncoscience-ag-cleared-for-phase-iii-trial-in-germany-with-nimotuzumaby.html

Get the life science industry in your inbox

YM BioSciences' partner, Oncoscience AG, cleared for Phase III trial in Germany with nimotuzumaby

New Health Boost Launches for Ageing Cats

Other news from the department business & finance

Merck Acquires JSR Chromatography Business

Novartis agrees to acquire Excellergy, Inc.

Growth in visitor numbers, full halls, clear future topics: analytica 2026 sets standards

Cellbricks Therapeutics Raises €10 Million New Capital to Move Living Tissue Implants Toward the Clinic

Berlin names Health Innovation Quarter Berlin-Mitte the new place of the future

US pharmaceutical company Merck is acquiring Terns Pharmaceuticals for around $6.7 billion

Rentschler Biopharma completes the largest expansion in the company’s history in the US

Evonik shortens the path from research to market readinessEvonik launches Innovation Factory

VTU Engineering Germany gets new managing director

German analysis and laboratory industry cautiously optimistic about the current year

Automation and robotics drive growth in the laboratory

Roche launches AI initiative to tackle lengthy development times

Sartorius is counting on a biopharma boom by 2030

Biotech start-up secures €23 million total for cancer and infectious disease platform

German biotech company chooses Saxony-Anhalt for protein production facility

Nine million euros for innovative cancer therapy

Tecan aims to bring unused lab data to life with NVIDIA

Start-up AveThera acquires Fraunhofer site for biologics production

Chemicals still in trouble

​​​3 questions to Susanne Grödl: AI and digital transformation shape analytica 2026

Get the life science industry in your inbox

Most read news

Start-up AveThera acquires Fraunhofer site for biologics production

BioNTech co-founders establish new biotech company

Plastic bottles turned into Parkinson’s medication

More meat, lower risk of dementia: study reveals gene-dependent effect

How old are we really?

Already approved drug is effective against aggressive brain tumors

Roche grows against the trend and invests over 700 million euros in Germany

Disastrous interplay: protein uncovered that makes cancer grow faster

Failed experiment by Cambridge scientists leads to surprise drug development breakthrough

Roche launches AI initiative to tackle lengthy development times

Contraception without hormones: Research alternatives to “the pill”

Vascular killer LDL cholesterol: are butter, eggs and cheese the culprits?

More news from our other portals

AI rebuilds molecules from exploding fragments

German food tech company secures €8 million to combat food waste

Non-destructive battery testing: New method developed

A flexible electrolyte for solid batteries

Amazonian cocoa could become a superfood

Chemical industry at a turning point: six keys to transformation

Why does oat milk sometimes foam perfectly and sometimes not at all?

WACKER cuts over 1,500 jobs to reduce costs by €300 million

How climate-friendly is insect protein really?

How a 270-year-old physics trick could supercharge affordable battery technology

How can startups revolutionize home cooking?

How are 360,000 tons of used batteries per year turned into a treasure trove of raw materials?

Research team achieves breakthrough in breeding winter-hardy faba beans

CO2 to E-Methanol, Aviation Fuels and Speciality Chemicals

BAM, HZB and HU are conducting joint research on sodium batteries

Tailor-made New Battery Materials

Energy storage breakthrough solves the fast-charging problem

Last viewed contents

University of Nottingham and BioFocus sign compound management agreement

Neurimmune Therapeutics Announces Advancement of Alzheimer’s Program into Preclinical Development

YM BioSciences reports Nimotuzumab approved for marketing in Mexico - YM enrolls first patients in multinational randomized, double-blind brain metastases trial

Bioassay Labor für biologische Analytik GmbH - Heidelberg, Germany

Ionix and Tripos collaborate on discovery of novel analgesics

3 questions to Susanne Grödl: AI and digital transformation shape analytica 2026